P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 209 500 KRW -4.34% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PharmaResearch Co Ltd
Cash Equivalents Peer Comparison

Comparables:
068270
302440
H
145020
N
007390
196170

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash Equivalents
â‚©2B
CAGR 3-Years
-56%
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash Equivalents
-â‚©440
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Bioscience Co Ltd
KRX:302440
Cash Equivalents
â‚©127B
CAGR 3-Years
72%
CAGR 5-Years
95%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash Equivalents
â‚©151.6B
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
N/A
N
NatureCell Co Ltd
KOSDAQ:007390
Cash Equivalents
â‚©26.7B
CAGR 3-Years
-13%
CAGR 5-Years
23%
CAGR 10-Years
32%
Alteogen Inc
KOSDAQ:196170
Cash Equivalents
â‚©37.8B
CAGR 3-Years
48%
CAGR 5-Years
45%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Cash Equivalents?
Cash Equivalents
2B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Cash Equivalents amounts to 2B KRW.

What is PharmaResearch Co Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
-41%

Over the last year, the Cash Equivalents growth was -97%. The average annual Cash Equivalents growth rates for PharmaResearch Co Ltd have been -56% over the past three years , -41% over the past five years .

Back to Top